Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Stem Cell Transplantation in T2DM
NCT00644241Phase 2Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jan 2008
- Primary completion
- Jun 2009
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived stem cells in type 2 diabetes mellitus (T2DM), sponsored by Post Graduate Institute of Medical Education and Research. Started Jan 2008; status: completed.
02
Drugs
autologous bone marrow-derived stem cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00644241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644241.